Four cycles of R-CHOP followed by two applications of rituximab based on negative interim PET/CT: an analysis of a prospective trial

BACKGROUND: R-CHOP with or without radiotherapy is the standard treatment for limited-stage diffuse large B-cell lymphoma (DLBCL). To prevent overtreatment, we assessed whether four cycles of CHOP plus six applications of rituximab was adequate with negative interim PET/CT and the role of consolidat...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Jia, Ji, Dongmei, Xia, Zuguang, Xue, Kai, Zhang, Qunling, Liu, Yizhen, Cao, Junning, Hong, Xiaonan, Gu, Juan J., Guo, Ye, Lv, Fangfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006508/
https://www.ncbi.nlm.nih.gov/pubmed/35418080
http://dx.doi.org/10.1186/s12885-022-09486-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006508/
https://www.ncbi.nlm.nih.gov/pubmed/35418080
http://dx.doi.org/10.1186/s12885-022-09486-4

Ejemplares similares